Horvātija -
horvātu -
HALMED (Agencija za lijekove i medicinske proizvode)
ambrisentan aop 5 mg filmom obložene tablete
aop orphan pharmaceuticals gmbh, leopold-ungar-platz 2, beč, austrija - ambrisentan - filmom obložena tableta - 5 mg - urbroj: svaka filmom obložena tableta sadrži 5 mg ambrisentana
Eiropas Savienība -
horvātu -
EMA (European Medicines Agency)
aspaveli
swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinuria, paroxysmal - imunosupresivi - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.
Eiropas Savienība -
horvātu -
EMA (European Medicines Agency)
epysqli
samsung bioepis nl b.v. - Экулизумаб - hemoglobinuria, paroxysmal - imunosupresivi - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.
Eiropas Savienība -
horvātu -
EMA (European Medicines Agency)
bekemv
amgen technology (ireland) uc - Экулизумаб - hemoglobinuria, paroxysmal - imunosupresivi - bekemv is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). dokaza klinički učinak očituje se u bolesnika s гемолизом s klinički simptom(ova), ukazuje na visoke aktivnosti bolesti, bez obzira na priče transfuziju (vidi odjeljak 5.